by Wiggin and Dana LLP | Sep 15, 2019
Plaintiffs in pharmaceutical personal injury litigation frequently join non-diverse, non-resident claims with those of resident plaintiffs in order to have all claims heard in a favorable state court. The proposed Fairness in Class Action Litigation Act of 2017...
by Wiggin and Dana LLP | Sep 15, 2019
Basic Information and Background The Guidance for Data Security uses the term confidential information to refer to various types of information that can be exchanged in the course of an arbitration, including the subsets of personally identifiable information (PII),...
by Wiggin and Dana LLP | Sep 15, 2019
Recent years have seen a substantial increase in the number of lawsuits filed in the United States against museums over artworks that changed hands during the Nazi period, whether due to alleged Nazi looting or alleged sales under duress due to Nazi persecution. While...